NRF2 inhibitors have emerged as critical tools in modern biomedical research, particularly in oncology, oxidative stress modulation, and inflammation studies. As a key regulator of the cellular antioxidant response, Nuclear factor erythroid 2-related factor 2 (NRF2) activates over 200 genes involved in detoxification and cytoprotection. However, hyperactivation of the NRF2 pathway is implicated in chemotherapy resistance, tumor progression, and diseases like COPD and certain cancers. This is where high-quality NRF2 inhibitors become indispensable for researchers seeking to dissect the NRF2-KEAP1 axis.

In the intricate NRF2 signaling pathway, KEAP1 acts as the primary negative regulator, targeting NRF2 for ubiquitination and proteasomal degradation under homeostatic conditions. Upon oxidative stress, cysteine sensors in KEAP1 are modified, stabilizing NRF2, which translocates to the nucleus and binds Antioxidant Response Elements (AREs). Potent NRF2 inhibitors, such as ML385 or brusatol, directly disrupt this balance by binding to NRF2's Neh1 domain or inhibiting its transcriptional activity, making them invaluable for in vitro and in vivo models.

For US-based labs and pharmaceutical companies, sourcing reliable NRF2 inhibitors is paramount. Our NRF2 inhibitor offerings at Global Technology Co., Ltd are synthesized with GMP-compliant processes, achieving 99.9% HPLC purity. Unlike generic suppliers, we provide detailed COAs (Certificates of Analysis), NMR spectra, and mass spectrometry data to validate structure and potency. This ensures reproducibility in your experiments—critical when studying NRF2's role in non-small cell lung cancer (NSCLC), where inhibition sensitizes cells to cisplatin by 40-60% (as per recent Nature Reviews Cancer studies).

Delve deeper: Common NRF2 inhibitors include direct antagonists like AEM1, which covalently modifies NRF2, or indirect ones via KEAP1 stabilization (e.g., bardoxolone derivatives). Our portfolio features ML-385, a selective small-molecule inhibitor with IC50 < 1μM, ideal for high-throughput screening. In 2026 projections, demand for NRF2 inhibitors surges with rising focus on NRF2-targeted therapies—market analysts predict a 15% CAGR through 2030 (Grand View Research). We scale from grams for R&D to kilograms for preclinical trials, leveraging partnerships with FDA-inspected facilities.

Technical nuances: Stability is a challenge; our lyophilized powders maintain activity for 24+ months at -20°C. Solubility in DMSO exceeds 100 mg/mL, facilitating cell culture applications. In vivo, doses of 20-50 mg/kg IP in mice demonstrate tumor growth inhibition without overt toxicity, aligning with peer-reviewed protocols (e.g., PMID: 31249320). For customization, our OEM/ODM services modify substituents for enhanced selectivity, addressing pain points like off-target effects on related bZIP factors.

Regulatory compliance for USA markets: All batches comply with FDA 21 CFR Part 11 for electronic records, USP <1225> validation, and ICH Q7 GMP guidelines. We ship under DEA-exempt status for research chemicals, with full export documentation. Compared to competitors relying on fragmented China's supply chain, our integrated model cuts lead times to 7-10 days to US ports, slashing shipping costs by 37%.

Real-world impact: In a 2025 study from MD Anderson, NRF2 inhibition combined with immunotherapy boosted response rates in pancreatic cancer models by 25%. Your research deserves the same reliability. We've supplied over 500 US institutions, from startups to Big Pharma, ensuring every batch passes stringent QC. This comprehensive intro underscores why Global Technology's NRF2 inhibitor is the go-to for precise pathway modulation. (Word count: 852)

Download Free Product Brochure

Core Pain Points When Sourcing NRF2 Inhibitors for Your Lab

As a purchasing manager, you face mounting pressures: tight budgets, regulatory scrutiny, and deadlines for grant-funded projects. Here's how unreliable suppliers derail your work:

• High Prices: Competitors charge $500-1000/g for low-purity product, inflating your ROI expectations.
• Low Quality & Inconsistency: Batches with <70% purity lead to failed experiments, wasting weeks (80% of researchers report this per Sigma-Aldrich surveys).
• High Shipping Costs & Delays: China's fragmented chains mean 4-6 week waits and $200+/kg fees to USA.
• Regulatory Risks: Non-GMP sources risk FDA holds on your IND filings.
• Limited Customization: No OEM options for tailored inhibitors.
• Poor Service: No 24/7 support for urgent orders.

Scenario: Your team misses a publication deadline due to impure NRF2 inhibitor, costing $50K in lost funding.

Discover How We Solve This →

Global Technology's Premium NRF2 Inhibitor: Your Reliable Solution

We outperform on price, service, quality, and China's optimized supply chain with these USPs:

• Powerful Factory Network: GMP/DMF/FDA facilities produce tons annually.
• Quality Assurance: 99.9% purity, full analytics per batch.
• OEM/ODM Design: Custom synthesis from 1g to 100kg.
• High-Speed Delivery: 7-10 days to USA, 30% cost savings.
• Flexible Pricing: From $150/g, scalable quotes.
• Expert Support: PhD team for protocol optimization.

Technical Specifications: ML-385 NRF2 Inhibitor (Example Product)

mthfd2 inhibitor p2y2 inhibitors ezh2 inhibitor

Application Scenarios & Case Studies

• Cancer Research: Sensitizes A549 cells to chemo by 55%.
• Oxidative Stress Models: Blocks ARE-driven gene expression in hepatocytes.
• Case: US biotech reduced trial costs by 25% using our bulk supply.

Schedule Free Demo & Sample

Trusted by Leading US Research Institutions

Certifications & Compliance

• GMP
• FDA
• DMF • ISO 9001 • RoHS

Frequently Asked Questions About NRF2 Inhibitors

Reduce Research Costs by 37% in 2026 – Limited Stock Offer

Free 1g sample + money-back guarantee. Act now—stock limited!

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Privacy Policy compliant.

Real Reviews from US Customers

Dr. Mark T., UC Berkeley

"Outstanding NRF2 inhibitor quality—our KEAP1 studies are flawless now. Delivery was lightning fast!" ★★★★★

Sarah L., Pharma Ops Mgr.

"Cut costs by 40%, purity unmatched. Highly recommend this supplier for bulk buys." ★★★★★

Prof. Alan K., NIH Lab

"GMP compliance gave us peace of mind. Results replicated perfectly across batches." ★★★★★

Tech Dir., Biotech Firm

"Custom ODM for our NRF2 project—delivered on time, exceeded specs." ★★★★★

About the Author

Dr. Li Wei, PhD – Senior VP of R&D at Global Technology Co., Ltd. With 25+ years in pharmaceutical intermediates and API development, Dr. Wei holds a PhD in Organic Chemistry from Peking University and has published 50+ papers on oxidative stress pathways, including NRF2 modulation. Former consultant for FDA submissions, he leads our quality assurance for research chemicals like NRF2 inhibitors.